These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26658664)

  • 21. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
    Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
    Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
    Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
    Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular lymphomas with plasmacytic differentiation include two subtypes.
    Gradowski JF; Jaffe ES; Warnke RA; Pittaluga S; Surti U; Gole LA; Swerdlow SH
    Mod Pathol; 2010 Jan; 23(1):71-9. PubMed ID: 19838161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
    Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
    Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
    Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
    Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas.
    Kim BK; Surti U; Pandya A; Cohen J; Rabkin MS; Swerdlow SH
    Am J Surg Pathol; 2005 Jan; 29(1):69-82. PubMed ID: 15613857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
    Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
    J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
    Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
    Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
    Kelley JT; Brown NA; Hristov AC; Bresler SC
    J Cutan Pathol; 2021 Jul; 48(7):969-974. PubMed ID: 33786907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy.
    Magnoli F; Marchiori D; Facchi S; Martin V; Campiotti L; Merli M; Sessa F; Tibiletti MG; Uccella S
    Cancer Genet; 2023 Jun; 274-275():1-9. PubMed ID: 36917896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
    Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
    Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
    Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
    Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral follicular lymphomas. A short report of 8 cases with assessment of the IGH/BCL2 gene fusion with fluorescence in situ hybridization.
    Argyris PP; Dolan M; Piperi E; Tosios KI; Pambuccian SE; Koutlas IG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):343-7. PubMed ID: 23953419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation.
    Karube K; Ying G; Tagawa H; Niino D; Aoki R; Kimura Y; Hashikawa K; Suefuji N; Sugita Y; Nomura Y; Shimizu K; Yoshida S; Seto M; Ohshima K
    Mod Pathol; 2008 Aug; 21(8):973-8. PubMed ID: 18500267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.